Clearstead Trust, LLC Novartis Ag Transaction History
Clearstead Trust, LLC
- $473 Million
- Q2 2025
A detailed history of Clearstead Trust, LLC transactions in Novartis Ag stock. As of the latest transaction made, Clearstead Trust, LLC holds 820 shares of NVS stock, worth $97,834. This represents 0.02% of its overall portfolio holdings.
Number of Shares
820
Previous 720
13.89%
Holding current value
$97,834
Previous $80,000
23.75%
% of portfolio
0.02%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding NVS
# of Institutions
1,550Shares Held
140MCall Options Held
1.69MPut Options Held
1.87M-
Dodge & Cox San Francisco, CA10.6MShares$1.27 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.24 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.08 Billion0.26% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$850 Million0.35% of portfolio
-
Morgan Stanley New York, NY7.06MShares$842 Million0.06% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $257B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...